SCHEMBL5872447

SCHEMBL5872447

CC(C)C1(C)N=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22800529 0.67
Hydrochloric Acid SCHEMBL22800530 0.67
Hydrochloric Acid SCHEMBL22800542 0.67
SCHEMBL10246547 0.61
SCHEMBL16002311 0.55
SCHEMBL3797017 0.50
SCHEMBL19334961 0.48
SCHEMBL4352 0.47
SCHEMBL674448 0.47
Hydrochloric Acid SCHEMBL5068272 0.44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-12202798-B2 Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes CFD RESEARCH CORPORATION (US) 2025-01-21 US disclosed
WO-2024112918-A1 RNA DEGRADERS AND USES THEREOF ARRAKIS THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed
US-20230365514-A1 MACROCYCLIC COMPOUNDS NOVO NORDISK RESEARCH CENTRE OXFORD LIMITED (GB) 2023-11-16 US disclosed
US-11807623-B2 Nucleic acid-binding photoprobes and uses thereof ARRAKIS THERAPEUTICS, INC. (US) 2023-11-07 US disclosed
US-20230312520-A1 NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF ARRAKIS THERAPEUTICS, INC. 2023-10-05 US disclosed
US-20230279426-A1 MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION LYCIA THERAPEUTICS, INC. 2023-09-07 US disclosed
US-20230250091-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. 2023-08-10 US disclosed
US-20230250091-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. 2023-08-10 US disclosed
US-20200399218-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RESEARCH CORPORATION 2020-12-24 US disclosed
US-20200216448-A1 INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1 UNIV CORNELL (US) 2020-07-09 US disclosed
US-20170362221-A1 INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-12-21 US disclosed
US-20160244494-A1 STABILIZED POLYPEPTIDES AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-08-25 US disclosed
US-7128576-B2 Adhesion promoters for silicone materials S & C POLYMER, SILICON- UND COMPOSITE-SPEZIALITATION GMBH (DE) 2006-10-31 US disclosed
US-20040010110-A1 Adhesion promoters for silicone materials S & C POLYMER, SILICON-UND COMPOSITE SPEZIALIZATION GMNH (DE) 2004-01-15 US disclosed
EP-1150641-B1 BONDING AGENTS FOR SILICONE MATERIALS S & C POLYMER SILICON & COMPOS (DE) 2003-05-02 EP disclosed
US-20020077441-A1 ADHESION PROMOTERS FOR SILCONE MATERIALS S & C POLYMER, SILICON-UND COMPOSITE-SPEZIALITATION GMBH (DE) 2002-06-20 US disclosed
EP-1150641-A1 BONDING AGENTS FOR SILICONE MATERIALS S & C Polymer Silicon- und Composite-Spezialitäten GmbH (DE) 2001-11-07 EP disclosed
WO-2000047164-A1 BONDING AGENTS FOR SILICONE MATERIALS S & C Polymer Silicon- und Composite-Spezialitäten GmbH (DE) 2000-08-17 WO disclosed